505 related articles for article (PubMed ID: 19306722)
1. [Cerebral aspergillosis in an HIV-infected patient: unsuccessful outcome despite combined antifungal therapy. ].
Gasch O; Fernández N; Ayats J; Santin M
Enferm Infecc Microbiol Clin; 2009 Mar; 27(3):193-4. PubMed ID: 19306722
[No Abstract] [Full Text] [Related]
2. Therapeutic and toxicologic studies in a murine model of invasive pulmonary aspergillosis.
Clemons KV; Schwartz JA; Stevens DA
Med Mycol; 2011 Nov; 49(8):834-47. PubMed ID: 21539507
[TBL] [Abstract][Full Text] [Related]
3. Novel antifungal agents as salvage therapy for invasive aspergillosis in patients with hematologic malignancies: posaconazole compared with high-dose lipid formulations of amphotericin B alone or in combination with caspofungin.
Raad II; Hanna HA; Boktour M; Jiang Y; Torres HA; Afif C; Kontoyiannis DP; Hachem RY
Leukemia; 2008 Mar; 22(3):496-503. PubMed ID: 18094720
[TBL] [Abstract][Full Text] [Related]
4. [Successful treatment of neuroaspergillosis in a patient with acute lymphoblastic leukemia: role of surgery, systemic antifungal therapy and intracavitary therapy].
Ozçelik T; Ozkalemkaş F; Kocaeli H; Altundal Y; Ener B; Ali R; Ozkocaman V; Hakyemez B; Tunali A
Mikrobiyol Bul; 2009 Jul; 43(3):499-506. PubMed ID: 19795628
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of voriconazole plus amphotericin B or micafungin in a guinea-pig model of invasive pulmonary aspergillosis.
Chandrasekar PH; Cutright JL; Manavathu EK
Clin Microbiol Infect; 2004 Oct; 10(10):925-8. PubMed ID: 15373889
[TBL] [Abstract][Full Text] [Related]
6. Voriconazole brain tissue levels in rhinocerebral aspergillosis in a successfully treated young woman.
Elter T; Sieniawski M; Gossmann A; Wickenhauser C; Schröder U; Seifert H; Kuchta J; Burhenne J; Riedel KD; Fätkenheuer G; Cornely OA
Int J Antimicrob Agents; 2006 Sep; 28(3):262-5. PubMed ID: 16908120
[TBL] [Abstract][Full Text] [Related]
7. [Update on therapy of invasive mycoses in hematology and oncology].
Maschmeyer G; Haas A; Böhme A
Dtsch Med Wochenschr; 2005 Jun; 130(22):1381-4. PubMed ID: 15915381
[No Abstract] [Full Text] [Related]
8. Long-term treatment of invasive sinus, tracheobroncheal, pulmonary and intracerebral aspergillosis in acute lymphoblastic leukaemia.
Björkholm M; Kalin M; Grane P; Celsing F
Infection; 2012 Feb; 40(1):81-5. PubMed ID: 21779887
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant endobronchial amphotericin B for refractory invasive pulmonary aspergillosis: evidence is scarce but promise does exist.
Stratakos G; Zakynthinos S
Respiration; 2007; 74(6):609-10. PubMed ID: 18037812
[No Abstract] [Full Text] [Related]
10. [Conservative management with new antifungals in a case of Candida prosthetic valve endocarditis].
Piñar D; Reus S; Pérez P; Quiles JA
Enferm Infecc Microbiol Clin; 2010 Jan; 28(1):66-7. PubMed ID: 19419799
[No Abstract] [Full Text] [Related]
11. Triple antifungal therapy for the treatment of invasive aspergillosis in a neutropenic pediatric patient.
Sims-McCallum RP
Am J Health Syst Pharm; 2003 Nov; 60(22):2352-6. PubMed ID: 14652986
[No Abstract] [Full Text] [Related]
12. Disseminated invasive aspergillosis in a patient with acute leukaemia.
Gottfredsson M; Steingrímsdóttir H
Acta Biomed; 2006; 77 Suppl 2():10-3. PubMed ID: 16918060
[TBL] [Abstract][Full Text] [Related]
13. Combination antifungal therapy for invasive aspergillosis.
Cesaro S; Visintin G
Clin Infect Dis; 2005 Apr; 40(7):1073-5; author reply 1075-6. PubMed ID: 15825015
[No Abstract] [Full Text] [Related]
14. [Progress in combination therapy for invasive aspergillosis].
Luo L; Tong Z
Zhonghua Jie He He Hu Xi Za Zhi; 2014 Jan; 37(1):41-4. PubMed ID: 24694973
[No Abstract] [Full Text] [Related]
15. A case of Aspergillus mediastinitis after heart transplantation successfully treated with liposomal amphotericin B, caspofungin and voriconazole.
Forestier E; Remy V; Lesens O; Martinot M; Hansman Y; Eisenmann B; Christmann D
Eur J Clin Microbiol Infect Dis; 2005 May; 24(5):347-9. PubMed ID: 15889298
[TBL] [Abstract][Full Text] [Related]
16. [Invasive multisystemic aspergillosis in an immunocompetent child: case report].
Donoso F A; Camacho A J; Alarcón L P; Cruces R P
Rev Chilena Infectol; 2006 Mar; 23(1):69-72. PubMed ID: 16462968
[TBL] [Abstract][Full Text] [Related]
17. Breakthrough pulmonary Aspergillus fumigatus infection with multiple triazole resistance in a Spanish patient with chronic myeloid leukemia.
Mellado E; De La Camara R; Buendía B; Rodriguez-Tudela JL; Cuenca-Estrella M
Rev Iberoam Micol; 2013 Jan; 30(1):64-8. PubMed ID: 22986228
[TBL] [Abstract][Full Text] [Related]
18. Strategy of following voriconazole versus amphotericin B therapy with other licensed antifungal therapy for primary treatment of invasive aspergillosis: impact of other therapies on outcome.
Patterson TF; Boucher HW; Herbrecht R; Denning DW; Lortholary O; Ribaud P; Rubin RH; Wingard JR; DePauw B; Schlamm HT; Troke P; Bennett JE; ;
Clin Infect Dis; 2005 Nov; 41(10):1448-52. PubMed ID: 16231256
[TBL] [Abstract][Full Text] [Related]
19. Cerebral aspergillosis due to Aspergillus fumigatus in AIDS patient: first culture-proven case reported in Brazil.
Vidal JE; Dauar RF; Melhem MS; Szeszs W; Pukinskas SR; Coelho JF; Lins DL; Costa SF; Penalva de Oliveira AC; Lacaz Cda S
Rev Inst Med Trop Sao Paulo; 2005; 47(3):161-5. PubMed ID: 16021291
[TBL] [Abstract][Full Text] [Related]
20. Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: a prospective, multicenter, observational study.
Singh N; Limaye AP; Forrest G; Safdar N; Muñoz P; Pursell K; Houston S; Rosso F; Montoya JG; Patton P; Del Busto R; Aguado JM; Fisher RA; Klintmalm GB; Miller R; Wagener MM; Lewis RE; Kontoyiannis DP; Husain S
Transplantation; 2006 Feb; 81(3):320-6. PubMed ID: 16477215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
